Page results
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
Macmillan Support and Information Service offer emotional support, advice and information to people affected by cancer and blood conditions.
-
This page aims to help you decide if a post-dates induction of labour is the right decision for you and your baby.
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding.
-
This page tells you about having a Port-a-cath Insertion (implantable port) with the Interventional Radiology team.
-
With all eyes on Paris for this summer’s Olympic Games, we look at how UCLH’s Institute of Sport, Health and Exercise (ISEH) has supported one of Britian’s Olympic hopefuls, and the care it provides for all kinds of sportspeople, from professionals to weekend warriors.
-
Emma, our support and information specialist, gives tips to overcome loneliness.
File results
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0371 - Acute myeloid leukaemia treatment
-
FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes
-
FOI/2024/0354 - Staff details for estates and facilities